Palliative care for interstitial lung disease: A nationwide survey of pulmonary specialists

Abstract

AbstractBackground and ObjectiveInterstitial lung disease (ILD) is progressive with high symptom burdens and poor prognosis. Patients with ILD need optimal palliative care to maintain their quality of life, however, few nationwide surveys have addressed palliative care for ILD.MethodsA nationwide, self‐administered questionnaire was conducted. Questionnaires were sent by mail to pulmonary specialists certified by the Japanese Respiratory Society (n = 3423). The current practices of PC for ILD, end‐of‐life communication, referral to a PC team, barriers to PC for ILD, and comparison of PC between ILD and lung cancer (LC).Results1332 (38.9%) participants completed the questionnaire, and the data of 1023 participants who had cared for ILD patients in the last year were analysed. Most participants reported that ILD patients often or always complained of dyspnoea and cough, but only 25% had referred them to a PC team. The timing of end‐of‐life communication tended to be later than the physician‐perceived ideal timing. The participants experienced significantly greater difficulty in symptomatic relief and decision‐making in PC for ILD compared to LC. Prescription of opioids for dyspnoea was less frequent for ILD than for LC. ILD‐specific barriers in PC included an ‘inability to predict prognosis’, ‘lack of established treatments for dyspnoea’, ‘shortage of psychological and social support’, and ‘difficulty for patients/families to accept the disease's poor prognosis’.ConclusionPulmonary specialists experienced more difficulty in providing PC for ILD compared to LC and reported considerable ILD‐specific barriers in PC. Multifaceted clinical studies are needed to develop optimal PC for ILD.